Delivery Order SPE2DR25D3504-SPE2DR26F7BV1
- Not listed
- The Defense Logistics Agency awarded a $2,524.95 delivery order to AmerisourceBergen Drug Corp for Climara Pro Patch 4S, a transdermal estrogen medication used in hormone replacement therapy. This competitively awarded, firm fixed-price contract was issued on September 17, 2025, with an ultimate completion date of September 18, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,285.98 to AmerisourceBergen Drug Corp for Climara Pro Patch 4S, a hormone replacement therapy product. This competitively awarded, firm fixed-price delivery order was issued on October 28, 2025, with an ultimate completion date of October 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,009.98 to AmerisourceBergen Drug Corp for Climara Pro Patch 4S, a hormone replacement therapy product. The contract was issued on September 23, 2025, with an ultimate completion date of September 24, 2025, under firm fixed price terms with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,996.37 to AmerisourceBergen Drug Corp for Climara Pro Patch 4S, a transdermal hormone replacement therapy product. This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,258.26 to AmerisourceBergen Drug Corp for the supply of Climara Pro Patch 4S, a transdermal estradiol hormone replacement therapy product. Issued on September 26, 2025, with an ultimate completion date of September 29, 2025, this firm fixed-price delivery order represents a competitive, non-set-aside award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,891.11 to AmerisourceBergen Drug Corp for Climara Pro Patch 4S, a transdermal hormone replacement therapy product. This competitively awarded, firm fixed-price delivery order was issued on August 18, 2025, with an ultimate completion date of August 19, 2025. The contract is being performed in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary distribution center for federal...
- The Defense Logistics Agency awarded a delivery order valued at $27,630.44 to AmerisourceBergen Drug Corp for the supply of Climara Pro Patch 4S, a transdermal hormone replacement therapy product. Issued on November 6, 2025, with completion targeted for November 7, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was made on a competitive basis with no set-aside designation, and performance will be...
- The Defense Logistics Agency awarded a delivery order valued at $2,038.24 to AmerisourceBergen Drug Corp for the supply of Climara Pro Patch 4S, a transdermal hormone replacement therapy medication. The award, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,427.77 to AmerisourceBergen Drug Corp for Climara Pro Patch 4S, a transdermal hormone replacement therapy medication. This non-set-aside, competitively awarded contract reflects a firm fixed price structure and is scheduled for completion by November 18, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $1,185.14 to AmerisourceBergen Drug Corp for Climara Pro Patch 4S, a transdermal hormone replacement therapy product. This non-set-aside, firm fixed-price delivery order was competitively awarded on November 18, 2025, with an ultimate completion date of November 19, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- SPE2DR25D3504Indefinite Delivery Contract
- SPE2DR25D3504-SPE2DR26F7BV1Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,408.21 to AmerisourceBergen Drug Corp for Climara Pro Patch 4S, a transdermal estradiol medication used in hormone replacement therapy. This firm fixed-price delivery order, issued on December 19, 2025, with an ultimate completion date of December 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). The award was competitively awarded with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999.999 billion IDC with DLA running through December 2026, which serves as the parent vehicle for this and numerous other delivery orders supporting military and federal healthcare systems globally. As a critical vendor in the federal medical procurement supply chain, AmerisourceBergen maintains the capability to fulfill diverse pharmaceutical and medical supply requirements through open competition, with its DLA contract portfolio encompassing a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 12/18/25 |